Uterine Pathology in Women Undergoing Minimally Invasive Hysterectomy Using Morcellation

Morcellation During Uterine Tissue Extraction AAGL Advancing Minimally Invasive Gynecology Worldwide I. Introduction: Minimally Invasive Surgery, Morcellation and the Scope of the Problem

The benefits of minimally invasive surgery (MIS) for treating a variety of gynecologic conditions are well documented [1-10]. Nearly half of the estimated 400,000 inpatient-based hysterectomies performed annually in the United States for benign indications employ these innovative techniques [11]. Thousands more women benefit from MIS in uterus-sparing procedures such as myomectomy. The ability ...

Updated Hysterectomy Surveillance and Factors Associated With Minimally Invasive Hysterectomy

BACKGROUND AND OBJECTIVES The goal of this study is to obtain updated surveillance statistics for hysterectomy procedures in the United States and identify factors associated with undergoing a minimally invasive approach to hysterectomy. METHODS A cross-sectional analysis of the 2009 United States Nationwide Inpatient Sample was performed. Subjects included all women aged 18 years or older wh...

Audit of Minimally Invasive Hysterectomy Rates: A Canadian Retrospective Cross-Sectional Database Review

Background: Minimally invasive hysterectomy is generally preferable to abdominal hysterectomy. The technicity index (TI) is the proportion of hysterectomies performed by minimally invasive surgery. Many centers globally have started to audit local TI as a quality indicator, but only a handful have published their results to help define international standards of care. <st...

When does Hysterectomy Replace Myomectomy in Benign Uterine Pathology?

FDA considers restricting or banning laparoscopic morcellation.

The U.S. Food and Drug Administration is considering restricting or banning morcellation in minimally invasive hysterectomies and myomectomies (removal of fibroids) because of new reports of higher incidence of undiagnosed sarcoma in women undergoing these procedures. Research now links morcellation to the spread, or upstaging, of undetectable gynecological cancers. In July, FDA convened a 2-da...